FT

UK to offer under-40s alternative to AstraZeneca vaccine

Declining infection rates mean potential risks from jab may outweigh dangers of disease

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button